OKYO Pharma Limited
OKYO
$1.60
$0.031.91%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.47% | 3.47% | 74.70% | 74.70% | 69.61% |
| Total Depreciation and Amortization | -33.33% | -33.33% | -22.22% | -22.22% | -40.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25,430.61% | 25,430.61% | -69.31% | -69.31% | -98.27% |
| Change in Net Operating Assets | -159.50% | -159.50% | -165.95% | -165.95% | 66.81% |
| Cash from Operations | -533.14% | -533.14% | 41.81% | 41.81% | 96.45% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 684.95% | 684.95% | -47.67% | -47.67% | -86.25% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 682.38% | 682.38% | -4.74% | -4.74% | -86.21% |
| Foreign Exchange rate Adjustments | 13.85% | 13.85% | 113.47% | 113.47% | -141.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,557.98% | 1,557.98% | 172.58% | 172.58% | 106.61% |